Document ID: chunk:federal_register_of_legislation:F2023L01749:schedule:1
Version: federal_register_of_legislation:F2023L01749
Segment Type: schedule
Provision Reference: sch 1
Character Range: 2470–3055

Schedule 1—Amendments

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019)
    [1]           Schedule 3, after entry for Hydromorphone in the form Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL
    insert:
Hydromorphone  Oral solution containing hydromorphone hydrochloride 1mg per mL, 1mL (S19A)

    [2]           Schedule 4, after entry for Levetiracetam
    insert:
Lumacaftor with ivacaftor  Sachet containing granules, lumacaftor 75 mg and ivacaftor 94 mg